| Value |
Category |
| 2nd line |
|
| 3 |
|
| 3 drug regimen |
|
| 3TC, TDF, EFV |
|
| 3TC. NVP. Zidovidine. (Triplova) |
|
| ALUVIA |
|
| AZT +3TC+EFV |
|
| AZT 300mg, NVP 200mg |
|
| AZT; TRUVADA; NVP |
|
| Alluvea, zidivudine |
|
| Aluvia. Lamiduvine. Tenofovir |
|
| Aluvia. Lamiduvine. Zidovidine |
|
| Aluvia/Lamivudine/TDF since MAY 2014 |
|
| HAART |
|
| HAART Not sure which |
|
| Lamiduvine. Aluvia. Zidovidine |
|
| NVP, lamivodine and zidovidine |
|
| NVP,3TC,TDF |
|
| NVP,LAMIVUDINE,STAVUDINE |
|
| Not recorded |
|
| Not specified |
|
| Second line |
|
| TDF, NVP, Lamivudine |
|
| TDF,D4T,NVP |
|
| TDF,Lamivudine,NVP |
|
| TDF/NVP/3TC |
|
| Tenofovir. Lamiduvine. Alluvia |
|
| not specified |
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.